Yulin Deng Selected Research

Glycoproteins (Glycoprotein)

7/2015	A pH-responsive soluble polymer-based homogeneous system for fast and highly efficient N-glycoprotein/glycopeptide enrichment and identification by mass spectrometry.
3/2015	[Synthesis of core-shell hydrophilic polymer-silica hybrid material and its application in N-glycan enrichment].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yulin Deng Research Topics

Disease

24	Neoplasms (Cancer) 04/2024 - 10/2009
20	Parkinson Disease (Parkinson's Disease) 01/2024 - 10/2008
9	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2020
8	Alzheimer Disease (Alzheimer's Disease) 03/2019 - 01/2012
7	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2015
6	Type 2 Diabetes Mellitus (MODY) 08/2023 - 11/2013
6	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 08/2011
5	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 06/2021
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 10/2019
5	Glioma (Gliomas) 01/2020 - 08/2011
4	Body Weight (Weight, Body) 01/2023 - 01/2008
4	Neuroblastoma 03/2019 - 02/2013
3	Hypoxia (Hypoxemia) 01/2024 - 06/2021
3	Neuroinflammatory Diseases 11/2021 - 05/2015
3	Brain Neoplasms (Brain Tumor) 01/2021 - 11/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 01/2017
2	Inflammation (Inflammations) 01/2024 - 10/2019
2	Major Depressive Disorder (Major Depressive Disorders) 10/2023 - 01/2022
2	Hyperglycemia 02/2019 - 04/2015
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2018
2	Pathologic Processes 01/2016 - 03/2015
2	Experimental Melanoma 10/2011 - 08/2008
2	Edema (Dropsy) 02/2010 - 08/2007
1	Sleep Wake Disorders 05/2024
1	Fatigue 05/2024
1	Brain Diseases (Brain Disorder) 10/2023
1	COVID-19 08/2023
1	Prediabetic State (Prediabetes) 08/2023
1	Depressive Disorder (Melancholia) 01/2023
1	Cognitive Dysfunction 01/2023

Drug/Important Bio-Agent (IBA)

13	NeurotoxinsIBA 03/2022 - 03/2013
12	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2014
10	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2012
6	SynucleinsIBA 01/2022 - 08/2011
5	salsolinolIBA 03/2022 - 03/2013
4	Peptides (Polypeptides)IBA 08/2023 - 08/2008
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 09/2014
4	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 03/2013
3	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 04/2004
3	Mechanistic Target of Rapamycin Complex 1IBA 05/2022 - 01/2018
3	LipidsIBA 04/2022 - 03/2019
3	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2019
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2021 - 04/2012
3	Amyloid (Amyloid Fibrils)IBA 03/2019 - 06/2012
2	Messenger RNA (mRNA)IBA 01/2024 - 01/2020
2	CytokinesIBA 01/2023 - 05/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 11/2017
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2020
2	Glycerolphosphate Dehydrogenase (Glycerol 3 Phosphate Dehydrogenase)IBA 06/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2016
2	ProteomeIBA 06/2020 - 11/2017
2	Amine Oxidase (Copper-Containing)IBA 04/2020 - 01/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2020 - 02/2019
2	EnzymesIBA 01/2020 - 11/2017
2	GlycosidesIBA 03/2018 - 07/2017
2	Dimethylnitrosamine (Nitrosodimethylamine)IBA 11/2017 - 01/2017
2	Therapeutic UsesIBA 03/2016 - 10/2011
2	Glycoproteins (Glycoprotein)IBA 07/2015 - 03/2015
2	Conditioned Culture MediaIBA 05/2015 - 06/2014
2	1,2,3,4-tetrahydroisoquinolineIBA 04/2015 - 02/2013
2	alpha-SynucleinIBA 06/2013 - 12/2009
2	Interleukin-2 (IL2)IBA 01/2013 - 10/2011
2	Acetic Acid (Vinegar)FDA LinkGeneric 02/2010 - 08/2007
2	Xylenes (Xylene)IBA 02/2010 - 08/2007
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2024
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2024
1	Levodopa (L Dopa)FDA LinkGeneric 01/2024
1	CopperIBA 01/2024
1	Tacrolimus Binding Proteins (FKBP)IBA 01/2024
1	graphdiyneIBA 01/2024
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2024
1	Photosensitizing Agents (Photosensitizers)IBA 01/2024
1	Coloring Agents (Dyes)IBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	Metal-Organic FrameworksIBA 01/2024
1	AlbuminsIBA 08/2023
1	Nucleic AcidsIBA 08/2023
1	Human Serum Albumin FDA LinkGeneric 08/2023
1	enzalutamideIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	Acetyl-CoA CarboxylaseIBA 01/2023
1	Carbon DioxideIBA 01/2023
1	NADP (NADPH)IBA 01/2023
1	Testosterone CongenersIBA 01/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	monomethoxypolyethylene glycol (MPEG)IBA 01/2023
1	Malondialdehyde (Propanedial)IBA 01/2023
1	Docetaxel (Taxotere)FDA Link 07/2022

Therapy/Procedure

17	Therapeutics 04/2024 - 01/2012
4	Immunotherapy 04/2024 - 10/2009
4	Radiotherapy 01/2021 - 10/2009
3	Drug Therapy (Chemotherapy) 01/2024 - 12/2013
1	Photochemotherapy (Photodynamic Therapy) 01/2024
1	Castration 01/2023